Valeant Research & Development
Records under this name other than patents Valeant Research & Development holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Valeant Research & Development
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,799,908 | Synthesis and Use of 2'-Substituted-N6-MODIFIED Nucleosides Formerly held In force · High confidence | In force | High confidence | |
| US 7,435,752 | N[S(4-ARYL-TRIAZOL-3-YL)ALPHA-MERCAPTOACETYL]-P-AMINO Benzoic Acids as HIV Reverse Transcriptase Inhibitors Formerly held Term ended Ended no later than Apr 1, 2026 · Medium confidence | Term ended | Ended no later than Apr 1, 2026 | Medium confidence |
| US 6,989,451 | Heterocyclic Compounds and Uses Thereof Term ended Term ended Jun 4, 2023 · High confidence | Term ended | Term ended Jun 4, 2023 | High confidence |
| US 7,371,857 | Synthesis for Hydroxyalkylated Heterocyclic Bases Term ended Term ended Oct 29, 2022 · High confidence | Term ended | Term ended Oct 29, 2022 | High confidence |
| US 7,683,087 | N[S(4-ARYL-TRIAZOL-3-YL)ALPHA-MERCAPTOACETYL] -P-Amino Benzoic Acids as HIV Reverse Transcriptase Inhibitors Lapsed on the fee record Ended Mar 23, 2022 · Medium confidence | Lapsed on the fee record | Ended Mar 23, 2022 | Medium confidence |
| US 7,638,496 | Nucleoside Analogs with Carboxamidine Modified Monocyclic Base Formerly held Lapsed on the fee record Ended Dec 29, 2021 · Low confidence | Lapsed on the fee record | Ended Dec 29, 2021 | Low confidence |
| US 7,056,895 | Tirazole Nucleoside Analogs and Methods for Using Same Formerly held Term ended Ended no later than Feb 20, 2021 · Low confidence | Term ended | Ended no later than Feb 20, 2021 | Low confidence |
| US 6,455,508 | Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides Term ended Term ended Oct 5, 2020 · From the USPTO record | Term ended | Term ended Oct 5, 2020 | From the USPTO record |
| US 7,429,667 | Phenylamino Isothiazole Carboxamidines as Mek Inhibitors Formerly held Lapsed on the fee record Ended Sep 30, 2020 · High confidence | Lapsed on the fee record | Ended Sep 30, 2020 | High confidence |
| US 6,815,542 | Nucleoside Compounds and Uses Thereof Term ended Term ended Jun 16, 2020 · Medium confidence | Term ended | Term ended Jun 16, 2020 | Medium confidence |